GlaxoSmithKline’s head of international pharmaceutical operations, Howard Pien, is to leave the company to become Chief Executive of Chiron.Mr Pien’s …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

